Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Glob Heart. 2023 Feb 10;18(1):3. doi: 10.5334/gh.1180. eCollection 2023.
As a surrogate for all relevant risk factors, it is preferable to show trends in the mean cardiovascular disease(CVD) risk rather than to examine each risk factor trend separately.
Using national representative data, this study aimed to determine the changes in the World Health Organization (WHO) CVD risk during the last decade considering both laboratory and non-laboratory risk scoring.
We used data from five rounds of the WHO STEPwise approach to surveillance surveys (2007-2016). In all, 62,076 (31,660 women) participants aged 40-65 years were included and their absolute CVD risk were calculated. The generalized linear model was performed to assess the trend of CVD risk in men and women, and also in diabetic and non-diabetic individuals.
We showed significant declining trends in the mean CVD risk in the laboratory (from 10.5% to 8.8%) and non-laboratory (10.1% to 9.4%) models in men. In women, a significant reduction was observed in the laboratory-based model (from 8.4% to 7.8%). The laboratory model showed a greater decrease in men than women (P-for interaction < 0.001) and in diabetic patients (from 16.1% to 13.6%) than non-diabetic individuals (from 8.2% to 7%) (p-for interaction = 0.002). The proportion of high-risk individuals (risk ≥ 10%) decreased from 40% in 2007 to 31.5% in 2016 in men and from 29.8% to 26.1% in women based on the laboratory-model.
During the last decade, CVD risk had a significant decrease in men and women. The reduction was more evident in men and diabetic population. However, still, one-third of our population is considered high-risk.
由于心血管疾病(CVD)的所有相关风险因素都可以作为替代指标,因此最好显示平均 CVD 风险的趋势,而不是分别检查每个风险因素的趋势。
本研究使用全国代表性数据,旨在考虑实验室和非实验室风险评分,确定过去十年中世界卫生组织(WHO)CVD 风险的变化情况。
我们使用了 WHO 逐步监测调查的五个回合的数据(2007-2016 年)。共纳入 62076 名(31660 名女性)年龄在 40-65 岁的参与者,并计算了他们的绝对 CVD 风险。采用广义线性模型评估男性和女性、糖尿病患者和非糖尿病患者 CVD 风险的趋势。
我们发现男性实验室(从 10.5%降至 8.8%)和非实验室(从 10.1%降至 9.4%)模型的平均 CVD 风险呈显著下降趋势。女性实验室模型也观察到显著降低(从 8.4%降至 7.8%)。实验室模型显示男性的降幅大于女性(P 交互<0.001),糖尿病患者(从 16.1%降至 13.6%)大于非糖尿病患者(从 8.2%降至 7%)(P 交互=0.002)。根据实验室模型,高危人群(风险≥10%)的比例从 2007 年的 40%男性和 29.8%女性降至 2016 年的 31.5%男性和 26.1%女性。
在过去十年中,男性和女性的 CVD 风险显著降低。男性和糖尿病患者的降幅更为明显。然而,仍有三分之一的人口被认为是高危人群。